A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma:a m

• 作 者: Cheng Xu Zhehui Yan Yuming Wang Liang Zhou
• 机 构: Institute of Infectious Diseases, Southwest Hospital, the Third Military Medical University,Chongqin
• 出 处: 第四届国际人体微生态大会、第十三届中华预防医学会微生态学学术会议、第五届中国医师协会感染科医师大会暨传染病诊治高峰论坛、
• 发表日期: 2013年期

　　Backgrounds Glypican-3(GPC-3) has been reported as one of the most promising serum markers for hepatocellular carcinoma (HCC),while several studies have conflicting results for the diagnostic accuracy between GPC-3 and alpha-fetoprotein (AFP).